首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1459628

全球宏基因组市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Metagenomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球宏基因组市场需求预计将从 2023 年的 23.8 亿美元达到 2032 年近 76.8 亿美元的市场规模，2024-2032 年研究期间CAGR为 13.91%。

宏基因体学是一种研究从水、土壤或人体等环境样本中回收的遗传物质的科学方法，无需分离和培养个体生物体。它提供了这些环境中微生物群落的遗传组成、多样性和功能潜力的见解，并使研究人员能够了解微生物在各种生态系统中的作用，包括它们对人类健康、农业和环境过程的影响。

市场动态

定序技术和生物资讯学工具的进步推动了宏基因组市场。宏基因组研究使科学家能够以前所未有的深度和准确性分析复杂的微生物群落。此外，人们对人类微生物组在健康和疾病中的作用的认识不断增强，刺激了个人化医疗、益生菌和微生物组疗法中对宏基因组解决方案的需求。此外，政府对微生物组科学研究的措施和资金支持透过促进学术、工业和政府机构之间的创新和合作加速了市场的成长。此外，宏基因体学在食品安全、工业生物加工和环境修復中的广泛应用凸显了其多功能性和市场潜力。然而，资料分析复杂性、标准化问题和有关遗传隐私的道德考虑等挑战可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球宏基因组市场的每个细分市场进行了包容性评估。宏基因组学产业的成长和趋势为这项研究提供了一种整体方法。

市场区隔

宏基因组市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

仪器
试剂盒和试剂
软体与服务

依技术

16S定序
全基因组定序
鸟枪式定序
其他的

按申请

生态与环境
临床诊断
药物发现
生物技术
食品和饮料
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲宏基因组学市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。宏基因体学市场的主要参与者包括Thermo Fisher Scientific, Inc.、Qiagen、Illumina, Inc.、Promega Corporation、Novogene Co., Ltd.、Takara Bio Inc.、Oxford Nanopore Technologies plc、Arc Bio, LLC、Eurofins Scientific 、 Zymo Research、Microsynth AG、F. Hoffmann-La Roche Ltd.、PerkinElmer, Inc.、Computomics GmbH。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：宏基因组公司的竞争格局

宏基因组市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

Qiagen

公司简介
公司收入
产品
最近的发展

Illumina Inc.

公司简介
公司收入
产品
最近的发展

Promega Corporation

公司简介
公司收入
产品
最近的发展

Novogene Co. Ltd.

公司简介
公司收入
产品
最近的发展

Takara Bio Inc.

公司简介
公司收入
产品
最近的发展

Oxford Nanopore Technologies plc

公司简介
公司收入
产品
最近的发展

Arc Bio LLC

公司简介
公司收入
产品
最近的发展

Eurofins Scientific

公司简介
公司收入
产品
最近的发展

Zymo Research

公司简介
公司收入
产品
最近的发展

Microsynth AG

公司简介
公司收入
产品
最近的发展

F. Hoffmann-La Roche Ltd.

公司简介
公司收入
产品
最近的发展

PerkinElmer Inc.

公司简介
公司收入
产品
最近的发展

Computomics GmbH

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112114033

The global demand for Metagenomics Market is presumed to reach the market size of nearly USD 7.68 Billion by 2032 from USD 2.38 Billion in 2023 with a CAGR of 13.91% under the study period 2024 - 2032.

Metagenomics is a scientific approach to studying genetic material recovered from environmental samples, such as water, soil, or the human body, without isolating and culturing individual organisms. It provides insights into microbial communities' genetic composition, diversity, and functional potential within these environments and allows researchers to understand microorganisms' roles in various ecosystems, including their impact on human health, agriculture, and environmental processes.

MARKET DYNAMICS

Advancements in sequencing technologies and bioinformatics tools drive the Metagenomics market. Metagenomic research has enabled scientists to analyze complex microbial communities with unprecedented depth and accuracy. Additionally, the growing awareness of the human microbiome's role in health and disease has fueled demand for metagenomic solutions in personalized medicine, probiotics, and microbiome therapeutics. Moreover, government initiatives and funding support for research in microbiome science have accelerated market growth by fostering innovation and collaboration among academic, industrial, and governmental institutions. Furthermore, the expanding use of metagenomics in food safety, industrial bioprocessing, and environmental remediation underscores its versatility and market potential. However, challenges such as data analysis complexity, standardization issues, and ethical considerations regarding genetic privacy may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metagenomics. The growth and trends of metagenomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the metagenomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Kits & Reagents
Software & Services

By Technology

16S Sequencing
Whole Genome Sequencing
Shotgun Sequencing
Others

By Application

Ecology & Environment
Clinical Diagnostics
Drug Discovery
Biotechnology
Food & Beverages
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Metagenomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Metagenomics market include Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Arc Bio, LLC, Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Computomics GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . METAGENOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL METAGENOMICS MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Kits & Reagents Historic and Forecast Sales by Regions
5.6 Software & Services Historic and Forecast Sales by Regions

6 . GLOBAL METAGENOMICS MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 16S Sequencing Historic and Forecast Sales by Regions
6.5 Whole Genome Sequencing Historic and Forecast Sales by Regions
6.6 Shotgun Sequencing Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL METAGENOMICS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Ecology & Environment Historic and Forecast Sales by Regions
7.5 Clinical Diagnostics Historic and Forecast Sales by Regions
7.6 Drug Discovery Historic and Forecast Sales by Regions
7.7 Biotechnology Historic and Forecast Sales by Regions
7.8 Food & Beverages Historic and Forecast Sales by Regions
7.9 Others Historic and Forecast Sales by Regions

8 . GLOBAL METAGENOMICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE METAGENOMICS COMPANIES

9.1. Metagenomics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF METAGENOMICS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Qiagen
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Illumina Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Promega Corporation
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Novogene Co. Ltd.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Takara Bio Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Oxford Nanopore Technologies plc
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Arc Bio LLC
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Eurofins Scientific
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Zymo Research
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Microsynth AG
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. F. Hoffmann-La Roche Ltd.
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. PerkinElmer Inc.
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Computomics GmbH
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments